2025-11-13T09:02:44-06:00 2024-12-31 410746749 CLIFTONLARSONALLEN LLP 950 NORTH GLEBE ROAD SUITE 1200 ARLINGTON VA 22203 990 2024-01-01 237045686 INFECTIOUS DISEASES SOCIETY OF AMERICA INFE 7032990200 4040 WILSON BOULEVARD 300 ARLINGTON VA 22203 BARTON GROH VP, FINANCE & ADMINISTRATION 7032990200 2025-11-11 1 0 ROBERT WILLIAMS P01345960 5715793002 2025-11-10 2024 2025-03-06 01:10:19Z IDSA CHRISTOPHER BUSKY 4040 WILSON BOULEVARD 300 ARLINGTON VA 22203 32259941 0 X WWW.IDSOCIETY.ORG X 1970 DC IMPROVE THE HEALTH OF SOCIETY BY PROMOTING EXCELLENCE IN PATIENT CARE, EDUCATION, RESEARCH, PUBLIC HEALTH AND PREVENTION OF INFECTIOUS DISEASES. 15 15 120 700 69463 30200 3445085 1416910 31529250 28617663 2006939 1475671 636964 749697 37618238 32259941 951405 1060246 0 0 14655026 15558551 0 0 0 21857467 22902394 37463898 39521191 154340 -7261250 68105366 66284980 16278116 17232049 51827250 49052931 X THE MISSION OF THE INFECTIOUS DISEASES SOCIETY OF AMERICA (IDSA) IS TO IMPROVE THE HEALTH OF INDIVIDUALS, COMMUNITIES, AND SOCIETY BY PROMOTING EXCELLENCE IN PATIENT CARE, EDUCATION, RESEARCH, PUBLIC HEALTH, AND PREVENTION OF INFECTIOUS DISEASES. IDSA'S WORK IS GUIDED BY A COMMITMENT TO SCIENCE, HEALTH EQUITY, AND TACKLING THE CHALLENGES OF INFECTIOUS DISEASES THROUGH ITS GLOBAL COMMUNITY OF EXPERTS. 0 0 IDWEEK ANNUAL CONFERENCE - IDWEEK 2024 IN LOS ANGELES, CA, ATTRACTED MORE THAN 10,000 ATTENDEES. THE MEETING IS THE WORLD'S PREMIER INFECTIOUS DISEASES EVENT. IDWEEK PROVIDES AN OPPORTUNITY FOR HEALTH PROFESSIONALS OF VARIED BACKGROUNDS TO LEARN FROM EACH OTHER'S KNOWLEDGE, EXPERIENCE AND EXPERTISE, FOR THE IMPROVEMENT OF PATIENT CARE AND PUBLIC HEALTH. THIS IS AN INCLUSIVE MEETING THAT OFFERS ACCESS TO INTERNATIONALLY RECOGNIZED LEADERS IN THE FIELD AND THE OPPORTUNITY TO NETWORK WITH THE MOST HIGHLY RESPECTED HEALTH PROFESSIONALS IN INFECTIOUS DISEASES, INCLUDING HIV. CLINICAL INFECTIOUS DISEASES (CID), THE JOURNAL OF INFECTIOUS DISEASES (JID) AND OPEN FORUM INFECTIOUS DISEASES (OFID) ARE SCHOLARLY JOURNALS PUBLISHED BY IDSA IN PARTNERSHIP WITH AN OUTSIDE PUBLISHER TO DISSEMINATE THE LATEST RESEARCH ON A VARIETY OF TOPICS IN THE FIELD TO MEMBERS AND SUBSCRIBERS. CID PUBLISHES ORIGINAL RESEARCH, REVIEWS AND PERSPECTIVES THAT ALL CLINICIANS CAN USE WHEN CARING FOR PATIENTS. CID COVERS THE CLINICAL PRESENTATION, DIAGNOSIS, TREATMENT AND PREVENTION OF THE FULL RANGE OF INFECTIOUS DISEASES. THE EVALUATION OF CURRENT AND NOVEL TREATMENTS, MICROBIOLOGY, IMMUNOLOGY AND POLICIES AS THEY RELATE TO PATIENT CARE ARE HIGHLY PRIORITIZED. PUBLISHED CONTINUOUSLY SINCE 1904, JID IS THE PREMIER GLOBAL JOURNAL FOR TRANSLATIONAL INFECTIOUS DISEASES SCIENCE. THE EDITORS WELCOME MAJOR ARTICLES AND BRIEF REPORTS DESCRIBING RESEARCH RESULTS ON MICROBIOLOGY, IMMUNOLOGY, EPIDEMIOLOGY, AND RELATED DISCIPLINES, ON THE PATHOGENESIS, DIAGNOSIS, AND TREATMENT OF INFECTIOUS DISEASES; ON THE MICROBES THAT CAUSE THEM; AND ON DISORDERS OF HOST IMMUNE RESPONSES. OFID PUBLISHES CLINICAL, TRANSLATIONAL AND BASIC RESEARCH IN A FULLY OPEN ACCESS, ONLINE JOURNAL. IT FOCUSES ON THE INTERSECTION OF BIOMEDICAL SCIENCE AND CLINICAL PRACTICE, WITH AN EMPHASIS ON KNOWLEDGE THAT COULD IMPROVE PATIENT CARE GLOBALLY. ARTICLES ARE WRITTEN BY EXPERTS IN THE FIELD, INCLUDING MEMBERS AND NON-MEMBERS, AND REVIEWED BY A PANEL OF LEADING MEDICAL EXPERTS BEFORE THEY ARE PUBLISHED. MEMBER SERVICES - IDSA MEMBER SERVICES PROVIDES TIMELY SCIENTIFIC INFORMATION, RELEVANT PUBLIC POLICY AND REGULATION, AND CAREER DEVELOPMENT RESOURCES. IDSA WAS AWARDED A COOPERATIVE AGREEMENT TO SUPPORT THE CDC BY PROVIDING RESOURCES TO FRONTLINE HEALTH CARE PROFESSIONALS CARING FOR PATIENTS WITH COVID-19. THE PARTNERSHIP BRINGS NUMEROUS MEDICAL SPECIALTIES TOGETHER TO SHARE RESOURCES AND TO PROVIDE THE LATEST INFORMATION AND GUIDANCE ON TREATING THOSE INFECTED WITH COVID-19 AND PREVENTING ITS SPREAD. THROUGH FUNDING FROM CDC, IDSA EXPERTS SUPPORT CDC'S CLINICAL CALL LINES, PROVIDING GUIDANCE TO HEALTH CARE PROVIDERS TREATING COVID-19 PATIENTS. THE COLLABORATION HAS ALSO FUNDED THE FLOURISHING COVID-19 REAL-TIME LEARNING NETWORK, AN ONLINE CENTER FOR FRONTLINE CLINICIANS TO LEARN, COLLABORATE AND SHARE TREATMENT BEST PRACTICES. IDSA'S COVID-19 PRACTICE GUIDELINES ON DIAGNOSTICS, TREATMENT AND MANAGEMENT ALSO RECEIVE FUNDING THROUGH THE GRANT. ADDITIONALLY, UNDER THE PARTNERSHIP, TWICE-MONTHLY CLINICIAN TELECONFERENCES PROVIDE HEALTH CARE PROFESSIONALS ACCESS TO EXPERTS WITH THE LATEST INFORMATION ON THIS EVOLVING VIRUS AS WELL AS AN OPPORTUNITY TO ASK QUESTIONS. THE CALLS FREQUENTLY DRAW MORE THAN 800 ATTENDEES. 0 1 0 1 0 0 0 0 0 1 1 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 177 0 1 120 0 1 1 0 0 0 1 1 0 0 0 X 15 15 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 0 0 X BARTON GROH VP FINANCE & ADMIN 7032990200 4040 WILSON BLVD NO 300 ARLINGTON VA 22203 CHRISTOPHER BUSKY CAE CHIEF EXECUTIVE OFFICER 32.50 5.00 X 711141 15664 86330 TY JOHNSON CHIEF OPERATING OFFICER 22.50 15.00 X 326268 104406 39915 DANA WOLLINS SVP, STRATEGY 37.50 0.00 X 284741 0 59916 AMANDA JEZEK SVP, POLICY & GOVERNMENT RELATIONS 37.50 0.00 X 273303 0 56806 SANDRA VURA HARWOOD VP, MEETINGS & EDUCATION 37.50 0.00 X 262084 0 44668 FELICITY CLANCY VP, MARKETING & MEMBERSHIP 37.50 0.00 X 242469 0 55197 ANDREA WEDDLE ED, HIVMA 36.50 1.00 X 239037 6374 33546 SALANDRA THOMAS VP, TALENT & ORG. DEVELOPMENT 34.50 3.00 X 228380 6090 46179 BARTON GROH VP, FINANCE & ADMINISTRATION 30.50 7.00 X 223970 11945 47706 RACHEL SHNEKENDORF SENIOR DIRECTOR, EDUCATION 37.50 0.00 X 179665 0 26955 JENNIFER MORALES SENIOR DIRECTOR, PR & MARKETING 37.50 0.00 X 177935 0 29493 GAYLE LEVY HARTMAN SENIOR DIRECTOR, DIGITAL & CONTENT STRATEGY 37.50 0.00 X 169138 0 53519 STEVEN K SCHMITT MD IMMED. PAST PRESIDENT AS OF 10/2024 2.00 0.00 X X 25000 0 0 TINA Q TAN MD PRESIDENT AS OF 10/2024 2.00 0.50 X X 7500 0 0 CARLOS DEL RIO MD IMMED. PAST PRESIDENT UNTIL 10/2024 2.00 0.00 X X 0 0 0 RONALD NAHASS MD PRESIDENT ELECT AS OF 10/2024 2.00 0.50 X X 0 0 0 WENDY S ARMSTRONG MD VICE PRESIDENT AS OF 10/2024 2.00 0.50 X X 0 0 0 MAXIMO BRITO MD TREASURER 2.00 0.50 X X 0 0 0 ROBIN TROTMAN MD SECRETARY 2.00 0.00 X X 0 0 0 ERIN BONURA MD DIRECTOR 1.00 0.00 X 0 0 0 ROBIN HENRY DRETLER MD DIRECTOR 1.00 0.00 X 0 0 0 MATIFADZA HLATSHWAYO DAVIS MD MPH DIRECTOR 1.00 0.00 X 0 0 0 HEATHER C YUN MD DIRECTOR 1.00 0.00 X 0 0 0 BONNIE M WORD MD DIRECTOR 1.00 0.00 X 0 0 0 DAVID ARONOFF MD DIRECTOR AS OF 10/2024 1.00 0.00 X 0 0 0 UPINDER SINGH MD DIRECTOR AS OF 10/2024 1.00 0.00 X 0 0 0 RAJESH T GHANDI MD DIRECTOR 1.00 0.00 X 0 0 0 KAMI KIM MD DIRECTOR 1.00 0.00 X 0 0 0 3350631 144479 580230 52 0 1 0 HART HEALTH STRATEGIES 3823 FORDHAM RD NW WASHINGTON DC 20005 CONSULTING 300000 ARENTFOX SCHIFF LLP 1717 K STREET NW WASHINGTON DC 20006 CONSULTING 175640 DRASHTI LLC 25527 BERESFORD DRIVE CHANTILLY VA 20152 CONSULTING 158400 PAUL E SAX 78 CROWNINSHIELD ROAD BROOKLINE MA 02446 CONSULTING 153340 COLLIER COLLECTIVE LLC 527 14TH STREET NE WASHINGTON DC 20002 CONSULTING 128500 6 1131324 285586 1416910 ANNUAL MEETING 900099 14354523 14354523 JOURNALS 900099 8157653 8157653 MEMBERSHIP DUES 900099 3012730 2948267 64463 MANAGEMENT FEES 900099 2199502 2199502 EDUCATION PROGRAMS 900099 889755 889755 3500 3500 28617663 1475671 1475671 552121 389759 5000 157362 UNBILLED COSTS 900099 130587 130587 OTHER REVENUE 900099 66989 66989 197576 32259941 28942959 69463 1830609 X 250000 298167 512079 2702916 10499131 598407 881465 876632 213573 57023 576750 162783 7944489 776818 2636112 683399 808969 1526650 6804342 426092 285394 39521191 1030120 2248992 1685037 1714366 3501022 2300038 745103 928159 3115468 1602868 1938692 1512600 46913163 44930525 4719232 5078418 7572997 7571882 68105366 66284980 2772658 4626755 4312114 4322565 9193344 8282729 16278116 17232049 X 51827250 49052931 51827250 49052931 68105366 66284980 -7261250 4486931 0 X 0 1 X 1 1 1 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 1 3410989 673239 -859938 -186699 272879 -459578 2034916 822925 1211991 521671 221062 300609 558881 558881 0 1512600 PRIVATELY HELD SEC. 5078418 F 5078418 DUE FROM AFFILIATES 1317997 SECURITY DEPOSIT 78720 RIGHT OF USE ASSET 5966033 457 ASSET 209132 7571882 457 LIABILITY 209132 LEASE LIABILITY 8073597 8282729 1 EAST ASIA 0 7 GRANTS TO RECIPIENTS GRANTS 6450 EAST ASIA 0 16 PROGRAM SERVICES AND ASSISTANCE TO RECIPIENTS LOCATED IN THE REGION TRAVEL REIMBURSEMENT AND HONORARIUM 136853 EUROPE 0 39 PROGRAM SERVICES AND ASSISTANCE TO RECIPIENTS LOCATED IN THE REGION HONORARIUM, JOURNAL PUBLISHING, AND TRAVEL REIMBURSEMENT 206665 NORTH AMERICA 0 10 PROGRAM SERVICES AND ASSISTANCE TO RECIPIENTS LOCATED IN THE REGION CONSULTING, HONORARIUM, SUBSCRIPTION, AND TRAVEL REIMBURSEMENT 65320 SOUTH AMERICA 0 10 PROGRAM SERVICES AND ASSISTANCE TO RECIPIENTS LOCATED IN THE REGION TRAVEL REIMBURSEMENT AND HONORARIUM 39891 MIDDLE EAST AND NORTH AFRICA 0 2 GRANTS TO RECIPIENTS GRANTS 3200 MIDDLE EAST AND NORTH AFRICA 0 3 PROGRAM SERVICES AND ASSISTANCE TO RECIPIENTS LOCATED IN THE REGION TRAVEL REIMBURSEMENT AND HONORARIUM 4935 SOUTH ASIA 0 12 GRANTS TO RECIPIENTS GRANTS 13700 SUB-SAHARAN AFRICA 0 2 PROGRAM SERVICES AND ASSISTANCE TO RECIPIENTS LOCATED IN THE REGION HONORARIUM 4000 CENTRAL AMERICA AND THE CARIBBEAN 0 1 PROGRAM SERVICES AND ASSISTANCE TO RECIPIENTS LOCATED IN THE REGION CONSULTING, HONORARIUM, SUBSCRIPTION, AND TRAVEL REIMBURSEMENT 2465 CENTRAL AMERICA AND THE CARIBBEAN 0 1 GRANTS TO RECIPIENTS GRANTS 1500 SUB-SAHARAN AFRICA 0 1 GRANTS TO RECIPIENTS GRANTS 1500 SOUTH AMERICA 0 1 GRANTS TO RECIPIENTS GRANTS 19500 EUROPE (INCLUDING ICELAND & GREENLAND) 0 1 GRANTS TO RECIPIENTS GRANTS 2500 NORTH AMERICA 0 4 GRANTS TO RECIPIENTS GRANTS 3600 0 99 0 11 0 110 477014 35065 512079 PROGRAM SERVICES AND ASSISTANCE TO RECIPIENTS LOCATED IN THE REGION SUB-SAHARAN AFRICA 2 4000 WIRE TRANSFER N/A N/A GRANTS TO RECIPIENTS SOUTH ASIA 12 13700 WIRE TRANSFER N/A N/A GRANTS TO RECIPIENTS SOUTH AMERICA 7 19500 WIRE TRANSFER N/A N/A PROGRAM SERVICES AND ASSISTANCE TO RECIPIENTS LOCATED IN THE REGION SOUTH AMERICA 10 39891 WIRE TRANSFER N/A N/A GRANTS TO RECIPIENTS NORTH AMERICA 4 3600 WIRE TRANSFER N/A N/A PROGRAM SERVICES AND ASSISTANCE TO RECIPIENTS LOCATED IN THE REGION NORTH AMERICA 10 65320 WIRE TRANSFER AND CHECK N/A N/A GRANTS TO RECIPIENTS MIDDLE EAST AND NORTH AFRICA 2 3200 WIRE TRANSFER N/A N/A PROGRAM SERVICES AND ASSISTANCE TO RECIPIENTS LOCATED IN THE REGION MIDDLE EAST AND NORTH AFRICA 3 4935 WIRE TRANSFER N/A N/A GRANTS TO RECIPIENTS EUROPE 1 2500 WIRE TRANSFER N/A N/A PROGRAM SERVICES AND ASSISTANCE TO RECIPIENTS LOCATED IN THE REGION EUROPE 39 206665 WIRE TRANSFER AND CHECK N/A N/A GRANTS TO RECIPIENTS EAST ASIA 7 6450 WIRE TRANSFER N/A N/A PROGRAM SERVICES AND ASSISTANCE TO RECIPIENTS LOCATED IN THE REGION EAST ASIA 16 136853 WIRE TRANSFER N/A N/A GRANTS TO RECIPIENTS CENTRAL AMERICA AND THE CARIBBEAN 1 1500 WIRE TRANSFER N/A N/A PROGRAM SERVICES AND ASSISTANCE TO RECIPIENTS LOCATED IN THE REGION CENTRAL AMERICA AND THE CARIBBEAN 1 2465 WIRE TRANSFER N/A N/A GRANTS TO RECIPIENTS SUB-SAHARAN AFRICA 1 1500 WIRE TRANSFER N/A N/A 0 0 0 0 0 0 PART I, LINE 2: THE ORGANIZATION MAINTAINS DETAILED RECORDS AND INTERNAL CONTROLS TO SUBSTANTIATE ALL GRANTS AND ASSISTANCE PROVIDED, INCLUDING DOCUMENTATION OF GRANT AMOUNTS, RECIPIENT ELIGIBILITY, PURPOSE, AND THE SELECTION AND APPROVAL CRITERIA. THESE RECORDS APPLY TO BOTH DOMESTIC AND INTERNATIONAL GRANTS SUPPORTING EDUCATION, RESEARCH, AND GLOBAL HEALTH PROGRAMS ALIGNED WITH THE ORGANIZATION'S MISSION. 1 IDSA EDUCATION AND RESEARCH FOUNDATION 4040 WILSON BLVD STE 300 ARLINGTON VA 22203 311765388 501(C)(3) 250000 0 N/A N/A PROGRAM SERVICE ACCOMPLISHMENTS 1 0 IDWEEK TRAVEL GRANTS 3 2400 N/A N/A IDWEEK KASS AWARDS 27 20250 N/A N/A IDWEEK DOMESTIC AWARDS 231 210700 N/A N/A IDWEEK CASE PRESENTER AWARDS 9 8900 N/A N/A IDWEEK DIAGNOSTICS AWARDS 3 6000 N/A N/A IDWEEK PROGRAM COMMITTEE CHOICE AWARDS 4 10000 N/A N/A SOCIETY AWARDS 34 39917 N/A N/A PART I, LINE 2: THE ORGANIZATION MAINTAINS COMPLETE RECORDS TO VERIFY GRANT AMOUNTS, CONFIRM GRANTEE ELIGIBILITY, AND DOCUMENT THE CRITERIA AND PROCESS USED TO EVALUATE AND AWARD ALL GRANTS AND ASSISTANCE. RECIPIENT ATTENDANCE, PARTICIPATION AND REPORTING ARE CONFIRMED BY STAFF PRIOR TO AWARD DISSEMINATION. X X X X 0 1 0 CHRISTOPHER BUSKY CAE CHIEF EXECUTIVE OFFICER 571733 15664 123744 0 15664 0 48820 1338 35207 965 795168 17967 0 0 TY JOHNSON CHIEF OPERATING OFFICER 221862 104406 0 0 104406 0 16629 7825 10513 4948 353410 117179 0 0 DANA WOLLINS SVP, STRATEGY 284741 0 0 0 0 0 22181 0 37735 0 344657 0 0 0 AMANDA JEZEK SVP, POLICY & GOVERNMENT RELATIONS 273303 0 0 0 0 0 21000 0 35806 0 330109 0 0 0 SANDRA VURA HARWOOD VP, MEETINGS & EDUCATION 262084 0 0 0 0 0 17983 0 26685 0 306752 0 0 0 FELICITY CLANCY VP, MARKETING & MEMBERSHIP 242469 0 0 0 0 0 16741 0 38456 0 297666 0 0 0 ANDREA WEDDLE ED, HIVMA 232663 6374 0 0 6374 0 17702 485 14949 410 271688 7269 0 0 SALANDRA THOMAS VP, TALENT & ORG. DEVELOPMENT 222290 6090 0 0 6090 0 17236 472 27712 759 273328 7321 0 0 BARTON GROH VP, FINANCE & ADMINISTRATION 212025 11945 0 0 11945 0 16540 932 28622 1612 269132 14489 0 0 RACHEL SHNEKENDORF SENIOR DIRECTOR, EDUCATION 179665 0 0 0 0 0 13574 0 13381 0 206620 0 0 0 JENNIFER MORALES SENIOR DIRECTOR, PR & MARKETING 177935 0 0 0 0 0 13631 0 15862 0 207428 0 0 0 GAYLE LEVY HARTMAN SENIOR DIRECTOR, DIGITAL & CONTENT S 169138 0 0 0 0 0 13675 0 39844 0 222657 0 0 0 PART I, LINE 3 CEO COMPENSATION: THE IDSA BOARD HAS ENTERED INTO AN EMPLOYMENT CONTRACT WITH ITS CHIEF EXECUTIVE OFFICER. THE COMPENSATION DETAILED IN THE CONTRACT AND SUBSEQUENT RAISES DURING THE CONTRACT TERM ARE BASED ON A REVIEW OF 990'S FROM OTHER SIMILAR NON-PROFIT ORGANIZATIONS, A COMPENSATION STUDY WRITTEN EMPLOYMENT CONTRACTS OF OTHER SIMILARILY SITUATED EXCECUTIVES, AND ANNUAL APPROVAL BY THE EXECUTIVE COMMITTEE. PART I, LINE 4B THE ORGANIZATION CONTRIBUTED $29,232 TO 457 PLANS FOR THE BENEFIT OF THE CEO. FORM 990, PART I, LINE 19, EXPLANATION OF DEFICIT: THE ORGANIZATION REPORTED AN OPERATING DEFICIT OF APPROXIMATELY $7 MILLION FOR THE FISCAL YEAR. THIS WAS A PLANNED AND BOARD-APPROVED INVESTMENT IN STRATEGIC INITIATIVES DESIGNED TO STRENGTHEN THE ORGANIZATION'S LONG-TERM IMPACT, MEMBER VALUE, AND MISSION DELIVERY. THE DEFICIT REFLECTS DELIBERATE SPENDING IN KEY AREAS, INCLUDING CONTINUED MODERNIZATION OF SYSTEMS AND INFRASTRUCTURE, EXPANDED MEMBER AND PUBLIC HEALTH PROGRAMS, AND INITIATIVES THAT REINFORCE THE INFECTIOUS DISEASES SPECIALTY'S LEADERSHIP AND VISIBILITY. THESE INVESTMENTS WERE MADE AS PART OF A MULTI-YEAR PLAN TO BUILD CAPACITY AND POSITION THE ORGANIZATION FOR SUSTAINED GROWTH AND EFFECTIVENESS. THE ORGANIZATION MAINTAINS ADEQUATE RESERVES TO FULLY COVER THIS PLANNED DEFICIT AND CONTINUES TO OPERATE WITH A STRONG FINANCIAL FOUNDATION. MEASURES ARE IN PLACE TO REDUCE FUTURE DEFICITS AND REBALANCE THE BUDGET OVER THE NEXT SEVERAL YEARS AS THE BENEFITS OF THESE STRATEGIC INVESTMENTS ARE REALIZED. FORM 990, PART VI, SECTION A, LINE 1A THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS CONSISTS OF THE PRESIDENT, VP, PRESIDENT-ELECT, PAST PRESIDENT, SECRETARY, & TREASURER - ARE RESPONSIBLE FOR THE MANAGEMENT AND DIRECTION OF THE ORGANIZATION AND CONDUCT THE AFFAIRS OF THE ORGANIZATION DURING INTERVALS BETWEEN MEETINGS OF THE BOD, FOR ASSISTING THE PRESIDENT IN THE OVERSIGHT OF THE ADMINISTRATIVE INFRASTRUCTURE OF THE SOCIETY, FOR SERVICE AS AN ADVISORY BODY TO THE PRESIDENT, AND FOR REPORTING ALL OF ITS ACTIONS TO THE BOD FOR REVIEW AND/OR APPROVAL. FORM 990, PART VI, SECTION A, LINE 6 THE CATEGORIES OF MEMBERSHIP INCLUDE: MEMBER, FELLOW, MEMBER-IN-TRAINING, ASSOCIATE MEMBER, AND MEDICAL STUDENT OR RESIDENT MEMBER. SOME MEMBERS OR FELLOWS MAY BE FURTHER CLASSIFIED AS HONORARY OR EMERITUS. FORM 990, PART VI, SECTION A, LINE 7A ALL MEMBERS OF THE BOARD OF DIRECTORS ARE SELECTED BY A LEADERSHIP DEVELOPMENT COMMITTEE OF MEMBERS BY REVIEWING CLINICAL EXPERIENCE, SERVICE WITHIN IDSA GOVERNANCE STRUCTURE AND APPLYING PRINCIPLES OF INCLUSION, DIVERSITY, ACCESS AND EQUITY. THE SLATE OF NEW BOARD MEMBERS IS THEN APPROVED BY THE BOARD AND ULTIMATELY BY THE FULL MEMBERSHIP. MEMBERS, MEMBERS-IN-TRAINING AND FELLOWS ARE FULL VOTING MEMBERS OF THE SOCIETY. FORM 990, PART VI, SECTION A, LINE 7B THE BYLAWS MAY BE AMENDED BY THE AFFIRMATIVE VOTE OF AT LEAST TWO-THIRDS (2/3) OF DIRECTORS PRESENT AND VOTING AT ANY REGULAR OR SPECIAL MEETING OF THE BOARD OF DIRECTORS. UPON THE WRITTEN REQUEST OF AT LEAST 10% OF THE VOTING MEMBERS, AN AMENDMENT MAY BE SUBMITTED TO THE BOARD OF DIRECTORS FOR CONSIDERATION AND VOTE AT THE NEXT BOARD OF DIRECTORS' MEETING. IF THE BOARD OF DIRECTORS DECIDE NOT TO PASS ANY MEMBER-PROPOSED AMENDMENT, THE BOARD OF DIRECTORS WILL SUBMIT THE MEMBER-PROPOSED AMENDMENT TO THE FULL MEMBERSHIP AT THE NEXT MEETING OF THE MEMBERS, AND SUCH MEMBER-PROPOSED AMENDMENT MAY BE ADOPTED BY THE AFFIRMATIVE VOTE OF AT LEAST TWO-THIRDS OF THE VOTING MEMBERS OF THE CORPORATION, PRESENT AND VOTING AT ANY REGULAR OR SPECIAL MEETING OF SUCH MEMBERS, IF NOTICE OF THE PROPOSED AMENDMENT IS CONTAINED IN THE NOTICE OF THE MEETING; OR BY AFFIRMATIVE VOTE OF AT LEAST TWO-THIRDS OF THOSE VOTING BY MAIL BALLOT. BYLAWS AMENDMENTS APPROVED BY THE BOARD OF DIRECTORS SHALL BE COMMUNICATED TO THE MEMBERS WITHIN SIXTY (60) DAYS OF APPROVAL. FORM 990, PART VI, SECTION B, LINE 11B A COPY OF THE FORM 990 IS ALSO PROVIDED TO EACH MEMBER OF THE BOARD OF DIRECTORS BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C IDSA REQUIRES ALL BOARD AND COMMITTEE MEMBERS, AS WELL AS KEY EMPLOYEES, TO SUBMIT A CONFLICT OF INTEREST (COI) FORM ANNUALLY. ANY INDIVIDUAL WITH A POTENTIAL CONFLICT MUST RECUSE THEMSELVES FROM RELATED DISCUSSIONS OR VOTES. STAFF MEMBERS WITH CONFLICTS ARE PROHIBITED FROM WORKING ON PROJECTS INVOLVING THE AFFECTED AREA OR COMPANY. THE COI AND ETHICS COMMITTEE OVERSEES COMPLIANCE WITH THIS POLICY. STAFF DISCLOSURES ARE REVIEWED BY THE CEO, WHO DETERMINES APPROPRIATE ACTION. THE CEO'S COI REPORT IS REVIEWED BY THE EXECUTIVE COMMITTEE, WHICH EVALUATES ANY POTENTIAL CONFLICTS INVOLVING THE CEO. FORM 990, PART VI, SECTION B, LINE 15A CEO COMPENSATION: (A) REVIEW AND APPROVAL IS DONE BY THE EXECUTIVE COMMITTEE, MEETING IN EXECUTIVE SESSION, (B) COMPARABILITY DATA IS OBTAINED FROM AMERICAN SOCIETY OF ASSOCIATION EXECUTIVES (ASAE) AND USED FOR DETERMINING COMPENSATION, (C) THERE ARE NO MINUTES OF THE EXECUTIVE SESSION, SO NO WRITTEN DELIBERATION. WRITTEN DECISION IS FORWARDED TO THE VP OF FINANCE AND ADMINISTRATION AND VP, TALENT & ORGANIZATIONAL DEVELOPMENT TO PLACE IN PERSONNEL FILE AND APPLIED TO PAYROLL. THESE PROCESSES WERE LAST COMPLETED IN 2024. FORM 990, PART VI, SECTION B, LINE 15B: EMPLOYEE COMPENSATION: COMPENSATION REVIEWED BY THE INDIVIDUAL'S SUPERVISOR AND APPROVED BY THE CEO. THE BOARD APPROVES THE OVERALL SALARY BUDGET BUT NOT INDIVIDUAL STAFF SALARIES, EXCEPT FOR THE CEO. COMPENSATION DECISIONS ARE INFORMED BY COMPARABILITY DATA OBTAINED FROM ASAE AND A COMPENSATION STUDY DONE BY A THIRD-PARTY CONSULTANT IN 2024. EMPLOYEE PERFORMANCE REVIEWS ARE DOCUMENTED, SIGNED BY BOTH THE SUPERVISOR AND EMPLOYEE, AND USED TO SUPPORT ANY RECOMMENDED SALARY ADJUSTMENTS. THESE PROCESSES WERE LAST COMPLETED IN 2024 FOR ALL STAFF. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS ARE AVAILABLE ON THE SOCIETY'S WEBSITE. UPON REQUEST, THEY ARE MADE AVAILABLE BASED ON BUSINESS NEED. THE AUDITED FINANCIAL STATEMENTS ARE AVAILABLE ON THE SOCIETY'S WEBSITE. THE CONFLICT OF INTEREST POLICY IS AVAILABLE ON OUR INTERNAL EMPLOYEE INTRANET AND DISTRIBUTED AS NEEDED. FORM 990, PART IX, LINE 11G PROGRAM CONSULTING 7,266,053. ALTERNATIVE INVEST FEES 18,537. OTHER PROFESSIONAL FEES 659,899. IDSA EDUCATION AND RESEARCH FOUNDATION 4040 WILSON BLVD STE 300 ARLINGTON VA 22203 311765388 FUNDING INITIATIVES DEDICATED TO SUPPORTING IDSA'S MISSION WORLDWIDE VA 501(C)(3) LINE 12A, I INFECTIOUS DISEASES SOCIETY OF AMERICA 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 IDSA EDUCATION AND RESEARCH FOUNDATION B 250000 COST IDSA EDUCATION AND RESEARCH FOUNDATION O 856638 COST IDSA EDUCATION AND RESEARCH FOUNDATION N 150678 COST